These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17515963)

  • 1. Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.
    Gemmati D; Federici F; Campo G; Tognazzo S; Serino ML; De Mattei M; Valgimigli M; Malagutti P; Guardigli G; Ferraresi P; Bernardi F; Ferrari R; Scapoli GL; Catozzi L
    Mol Med; 2007; 13(1-2):112-20. PubMed ID: 17515963
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Ansani L; Marchesini J; Pestelli G; Luisi GA; Scillitani G; Longo G; Milani D; Serino ML; Tisato V; Gemmati D
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
    Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
    Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of gene polymorphisms in ulcer healing process after superficial venous surgery.
    Gemmati D; Tognazzo S; Catozzi L; Federici F; De Palma M; Gianesini S; Scapoli GL; De Mattei M; Liboni A; Zamboni P
    J Vasc Surg; 2006 Sep; 44(3):554-62. PubMed ID: 16950433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker?
    Gemmati D; Zeri G; Orioli E; Mari R; Moratelli S; Vigliano M; Marchesini J; Grossi ME; Pecoraro A; Cuneo A; Ferrari R; Pinotti M; Serino ML; Ansani L
    Thromb Haemost; 2015 Jul; 114(1):123-32. PubMed ID: 25947356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.
    Butt C; Zheng H; Randell E; Robb D; Parfrey P; Xie YG
    Blood; 2003 Apr; 101(8):3037-41. PubMed ID: 12480694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore.
    Heng CK; Lal S; Saha N; Low PS; Kamboh MI
    Hum Genet; 2004 Jan; 114(2):186-91. PubMed ID: 14593529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII B subunit polymorphisms and the risk of coronary artery disease.
    Mezei ZA; Bereczky Z; Katona É; Gindele R; Balogh E; Fiatal S; Balogh L; Czuriga I; Ádány R; Édes I; Muszbek L
    Int J Mol Sci; 2015 Jan; 16(1):1143-59. PubMed ID: 25569091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIIIA-V34L and factor XIIIB-H95R in venous thromboembolism in central Iran: protective and neutral.
    Pourgheysari B; Drees F; Hashemzadeh-Chaleshtori M
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):439-43. PubMed ID: 24509329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of genes affecting thrombosis and risk of myocardial infarction.
    Kakko S; Elo T; Tapanainen JM; Huikuri HV; Savolainen MJ
    Eur J Clin Invest; 2002 Sep; 32(9):643-8. PubMed ID: 12486862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation factor XIII activity predicts left ventricular remodelling after acute myocardial infarction.
    Frey A; Gassenmaier T; Hofmann U; Schmitt D; Fette G; Marx A; Herterich S; Boivin-Jahns V; Ertl G; Bley T; Frantz S; Jahns R; Störk S
    ESC Heart Fail; 2020 Oct; 7(5):2354-2364. PubMed ID: 32548915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
    El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
    Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII val34leu and the risk of myocardial infarction.
    Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
    Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
    Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.
    Nahrendorf M; Hu K; Frantz S; Jaffer FA; Tung CH; Hiller KH; Voll S; Nordbeck P; Sosnovik D; Gattenlöhner S; Novikov M; Dickneite G; Reed GL; Jakob P; Rosenzweig A; Bauer WR; Weissleder R; Ertl G
    Circulation; 2006 Mar; 113(9):1196-202. PubMed ID: 16505171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
    Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
    Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
    Balogh L; Katona É; Mezei ZA; Kállai J; Gindele R; Édes I; Muszbek L; Papp Z; Bereczky Z
    Mol Cell Biochem; 2018 Nov; 448(1-2):199-209. PubMed ID: 29484525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.
    Ambroziak M; Kuryłowicz A; Budaj A
    J Thromb Thrombolysis; 2019 Oct; 48(3):519-527. PubMed ID: 30972713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing and long-term prognosis of recurrent MI after primary angioplasty : Stent thrombosis vs. non-stent-related reinfarction.
    Viveiros Monteiro A; Ramos R; Fiarresga A; de Sousa L; Cacela D; Patrício L; Bernardes L; Soares C; Cruz Ferreira R
    Herz; 2017 Apr; 42(2):186-193. PubMed ID: 27363417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.